Valens Semiconductor (NYSE: VLN) warrants face NYSE delisting in July 2026

Rhea-AI Filing Summary

Valens Semiconductor Ltd. states that New York Stock Exchange staff have determined to commence proceedings to delist its warrants to purchase one-half of one ordinary share, traded under ticker VLNW, due to “abnormally low selling price” levels under Section 802.01D of the NYSE Listed Company Manual. Trading in these warrants is expected to be suspended on July 24, 2026.

The warrants will remain outstanding and exercisable at an exercise price of $11.50 per one ordinary share until their expiration on September 29, 2026. Trading of the company’s ordinary shares on the NYSE under ticker VLN will continue and is not impacted by this action.

Positive

• None.

Negative

• NYSE delisting of VLNW warrants due to “abnormally low selling price” will end NYSE trading in these warrants on July 24, 2026, reducing liquidity and price transparency for warrant holders.

Filing Explained

The Form 6-K is incorporated by reference into the company’s specified Form F-3 and Form S-8 registration statements, making this report part of those filings unless later documents supersede it.

Key Figures

Warrant trading suspension date: July 24, 2026 Warrant expiration date: September 29, 2026 Warrant exercise price: $11.50 per one ordinary share

3 metrics

Warrant trading suspension date July 24, 2026 Date NYSE will suspend trading of VLNW warrants

Warrant expiration date September 29, 2026 Expiration date of Valens Semiconductor warrants

Warrant exercise price $11.50 per one ordinary share Exercise price for each outstanding warrant until expiration

Key Terms

abnormally low selling price, Section 802.01D, warrants to purchase one-half of one ordinary share, exercise price

4 terms

abnormally low selling price regulatory

"The determination was based on “abnormally low selling price” levels"

Section 802.01D regulatory

"levels, pursuant to Section 802.01D of the NYSE Listed Company Manual"

warrants to purchase one-half of one ordinary share financial

"the Company’s warrants to purchase one-half of one ordinary share"

exercise price financial

"each may be exercised at an exercise price of $11.50 per one ordinary share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

Available on EDGAR 07/24/2026 - 04:00 PM Accepted by SEC EDGAR 07/24/2026 - 04:00 PM Learn about SEC filing dates

FAQ

What did Valens Semiconductor (VLN) disclose about its NYSE-listed warrants?

Valens Semiconductor reported that NYSE staff will commence proceedings to delist its VLNW warrants for “abnormally low selling price” levels. Trading in the warrants on the NYSE is expected to be suspended on July 24, 2026, although the warrants themselves remain outstanding until expiration.

When will Valens Semiconductor’s VLNW warrants be suspended and when do they expire?

Trading of Valens Semiconductor’s VLNW warrants on the NYSE will be suspended on July 24, 2026. The warrants remain outstanding and can be exercised until their expiration date on September 29, 2026, after which they will no longer be exercisable.

At what price can Valens Semiconductor’s VLNW warrants be exercised?

Each VLNW warrant may be exercised at an exercise price of $11.50 per one ordinary share of Valens Semiconductor. This exercise price applies for as long as the warrants remain outstanding, up to their stated expiration on September 29, 2026.

Does the NYSE delisting of VLNW warrants affect Valens Semiconductor’s ordinary shares (VLN)?

The NYSE action applies only to the VLNW warrants. Valens Semiconductor’s ordinary shares, traded under ticker VLN, will continue trading on the NYSE and are stated as not impacted by the warrant delisting proceedings.

Why are Valens Semiconductor’s VLNW warrants being delisted from the NYSE?

NYSE staff determined to begin delisting proceedings for Valens Semiconductor’s VLNW warrants based on “abnormally low selling price” levels. This determination was made under Section 802.01D of the NYSE Listed Company Manual, which addresses such pricing issues.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2026

Commission File Number: 001-40842

VALENS SEMICONDUCTOR LTD.

(Exact name of registrant as specified in its charter)

8 Hanagar St. POB 7152

Hod Hasharon 4501309

Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒      Form 40-F ☐

EXPLANATORY NOTE

Warrant Delisting

Valens Semiconductor Ltd. (the “Company”) was notified by the New York Stock Exchange (“NYSE”) that the NYSE staff have determined to commence proceedings to delist the Company’s warrants to purchase one-half of one ordinary share of the Company (the “Warrants”), under the ticker VLNW, from NYSE on July 24, 2026. The determination was based on “abnormally low selling price” levels, pursuant to Section 802.01D of the NYSE Listed Company Manual. Trading in the Warrants on the NYSE will be suspended as of July 24, 2026. The Warrants remain outstanding until their expiration date on September 29, 2026 and until such time each may be exercised at an exercise price of $11.50 per one ordinary share.

Trading in the Company’s ordinary shares under the ticker VLN will continue on the NYSE and not be impacted.

This Form 6-K is incorporated by reference into the Registrant’s registration statement on Form F-3 (Securities and Exchange Commission File No. 333-260390) and Form S-8 (File Nos. 333-259849, 333-269250, 333-276520 and 333-293747), and will be a part thereof from the date on which this Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	VALENS SEMICONDUCTOR LTD.
	By:	/s/ Yoram Salinger
		Name	Yoram Salinger
		Title:	Chief Executive Officer

Date: July 24, 2026

2